Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 112.85 INR
Change Today 0.00 / 0.00%
Volume 0.0
KPH On Other Exchanges
Symbol
Exchange
Mumbai
As of 7:40 AM 01/6/15 All times are local (Market data is delayed by at least 15 minutes).

kappac pharma ltd (KPH) Snapshot

Open
--
Previous Close
112.85
Day High
--
Day Low
--
52 Week High
03/31/14 - 702.00
52 Week Low
01/6/15 - 112.85
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
-0.04
Shares Outstanding
23.8M
EX-Date
11/27/00
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for KAPPAC PHARMA LTD (KPH)

Related News

No related news articles were found.

kappac pharma ltd (KPH) Related Businessweek News

No Related Businessweek News Found

kappac pharma ltd (KPH) Details

Kappac Pharma Limited does not have significant operations. Previously, it was engaged in manufacturing pharmaceutical products. The company was incorporated in 1981 and is based in Mumbai, India.

Founded in 1981

kappac pharma ltd (KPH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kappac pharma ltd (KPH) Key Developments

Kappac Pharma Ltd. Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Kappac Pharma Ltd. reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, loss from operation before other income, interest and exceptional items was INR 0.118 million against INR 0.038 million a year ago. Loss from ordinary activities before tax was INR 0.118 million against INR 0.038 million a year ago. Net loss was INR 0.118 million or INR 0.00 per basic and diluted share against INR 0.038 million or INR 0.00 per basic and diluted share a year ago. For the nine months, loss from operation before other income, interest and exceptional items was INR 0.439 million against INR 0.265 million a year ago. Loss from ordinary activities before tax was INR 0.439 million against INR 0.265 million a year ago. Net loss was INR 0.439 million or INR 0.02 per basic and diluted share against INR 0.265 million or INR 0.01 per basic and diluted share a year ago.

Kappac Pharma Ltd., Board Meeting, Feb 10, 2015

Kappac Pharma Ltd., Board Meeting, Feb 10, 2015. Agenda: To consider unaudited standalone earnings results for the third quarter and nine months ended December 31, 2014.

Kappac Pharma Ltd. Accepts Resignation of Mr. Anand Trivedi from the Board of Director

Kappac Pharma Ltd. announced that the Board of Directors of the company at its meeting held on January 28, 2015 has considered to accept resignation of Mr. Anand Trivedi, from the Board of Director of the company.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KPH:IN 112.85 INR 0.00

KPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for KPH.
View Industry Companies
 

Industry Analysis

KPH

Industry Average

Valuation KPH Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 9.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KAPPAC PHARMA LTD, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.